Form D · Other Health Care

ACON BioMatrix Investors I, L.L.C.

Washington, DC · CIK 0001691205

Offering snapshot reported Dec 1, 2016 · SEC filing

Reported sold: $57.5M
Investors reported: 2
Minimum accepted: $0
First sale: Nov 17, 2016

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 1, 2016	Initial	$57,500,000	No comparison	2	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-275478

Source: Form D, filed Dec 1, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

ACON BIOMATRIX INVESTORS I, L.L.C.

Investment adviser: ACON EQUITY MANAGEMENT, L.L.C.

Gross asset value: $1.24M
Beneficial owners: 2
ADV minimum commitment: $500K

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SEI GLOBAL SERVICES, INC. OAKS, Pennsylvania, United States Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →

Auditor PRICEWATERHOUSECOOPERS MCLEAN, Virginia, United States Other funds reporting this name →

Custodian WELLS FARGO BANK, N.A. MCLEAN, Virginia, United States Related to adviser: No Other funds reporting this name →

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

PRICEWATERHOUSECOOPERS
PCAOB 238

WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09

Fund asset history · 5 annual observations

Scroll to see all columns →

Fiscal year	Gross assets	Beneficial owners	ADV filed
2021	$143,825,101	2	Mar 31, 2022
2022	$142,261,533	2	Mar 31, 2023
2023	$141,104,745	2	Mar 29, 2024
2024	$1,477,792	2	Mar 31, 2025
2025	$1,240,326	2	Mar 31, 2026

Filing source

Form ADV 2081248 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-9524249603

Reported by ACON EQUITY MANAGEMENT, L.L.C. (CRD 159517).

Annual Updating Amendment for Registered Adviser · fiscal year 2025.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Not Applicable Acon Equity Management, L.L.C.	Executive
Bernard Aronson	Executive
Teresa Bernstein	Executive
Andre Bhatia	Executive
Kenneth R. Brotman	Executive
Jonathan Ginns	Executive
Daniel Jinich	Executive
Barry Johnson	Executive
Aron Schwartz	Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

1133 Connecticut Ave. N.W.
Washington, DC, 20036
Phone: 202-454-1100